References
- McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Veno-occlusive disease of the liver after bone marrow transplantation: Diagnosis, incidence, and predisposing factors. Hepatology 1984, 4, 116–122.
- Jones RJ, Lee KS, Beschorner WE, et al. Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation 1987, 44, 778–783.
- Cesaro S, Pillon M, Talenti E, et al. A prospective survey on incidence, risk factor and therapy of hepatic veno-occlusive disease in children after haematopoietic stem cell transplantation. Hematologica 2005, 90, 1396–1404.
- D’Antiga L, Baker A, Pritchard J, et al. Veno-Occlusive with multiorgan involvement following actinomycin D. Eur. J. Cancer 2001, 7, 1141–1148.
- Reiss U, Cowan M, McMillan A, Horn B. Hepatic veno-occlusive disease in blood and bone marrow transplantation in children and young adults: Incidence risk factor and outcome in a cohort of 241 patients. J. Pediatr. Hematol. Oncol. 2002, 24, 746–750.
- Corbacioglu S, Greil J, Peters C, et al. Defibrotide in the treatment of children with VOD: A retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transplant. 2004, 33, 189–195.
- Sulis ML, Bessmertny O, Granowetter L, et al. Veno-Occlusive disease in pediatric patients receiving actinomycin D and vincristine only for the treatment of rhabdomyosarcoma. J. Pediatr. Hematol. Oncol. 2004, 26, 843–846.
- McDonald GB, Hinds MS, Fisher LD, et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients. Ann. Intern. Med. 1993, 118, 255–267.
- Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995, 85, 3005–3020.
- Senzolo M, Germani G, Cholongitas E, et al. Veno occlusive disease: Update on clinical management. World J. Gastroenterol. 2007, 13, 3918–3924.
- Akyuz C, Caclar K, Emir S, Büyükpamukçu M. High-dose methylprednisolone treatment of hepatic veno-occlusive disease in a child with Wilms tumor. Pediatr. Hematol. Oncol. 2003, 20, 345–349.
- Shulman HM, Fisher LB, Schoch HG, et al. Venoocclusive disease of the liver after marrow transplantation: Histological correlates of clinical signs and symptoms. Hepatology 1994, 19, 1171–8.
- Lee JH, Lee KH, Kim S, et al. Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of veno-occlusive disease in patients undergoing allogenic bone marrow transplantation: A prospective study. Bone Marrow Transplant. 1998, 22, 883–888.
- Ho VT, Revta C, Richardson PG. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: Update on defibrotide and other current investigational therapies. Bone Marrow Transplant. 2008, 41, 229–37.
- Del Toro G. Defibrotide in sinusoidal obstruction syndrome: Mounting evidence in pediatric patients. Pediatr. Blood Cancer 2008, 50, 735–6.
- Bulley SR, Strahm B, Doyle J, Dupuis LL. Defibrotide for the treatment of hepatic veno-occlusive disease in children. Pediatr. Blood Cancer 2007, 48, 700–4.
- Bairey O, Kirgner I, Yacobi M, et al. Clinical severe hepatic veno-occlusive disease during induction treatment of acute monoblastic leukemia managed with defibrotide. Am. J. Hematol. 2002, 69, 281–4.
- Kraemer DM, Waschke J, Kunzmann V, Wilhelm M. Veno-occlusive disease in a male patient with Marfan syndrome and common acute lymphoblastic leukemia during induction therapy. Ann. Hematol. 2003, 82, 444–7.
- Papadopoulos A, Ntaios G, Kaiafa G, et al. Veno-occlusive disease of the liver during induction therapy for acute lymphoblastic leukemia. Int. J. Hematol. 2008, 88, 441–2.
- Qureshi A, Marshall L, and Lancaster D. Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children. Pediatr. Blood Cancer 2008, 50, 831–2.